Corticotropin-releasing factor (CRF), also known as corticotropin-releasing hormone (CRH), is a 41-amino acid peptide that serves as the primary regulator of the hypothalamic-pituitary-adrenal (HPA) axis and mediates stress responses throughout the brain. CRF neurons are distributed across several brain regions and play critical roles in stress-related disorders and neurodegenerative diseases. [1]
CRF is the principal initiator of the stress response, coordinating behavioral, autonomic, and endocrine adaptations to threats. Dysregulation of CRF signaling has been implicated in depression, anxiety disorders, and neurodegenerative diseases [1]. [2]
| Property | Value | [3]
|----------|-------| [4]
| Peptide | CRH/CRF (41 amino acids) | [5]
| Gene | CRH (Chromosome 8q13) |
| Receptors | CRHR1, CRHR2 |
| Primary location | Paraventricular nucleus (PVN) |
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:4072021 | corticotropin-releasing neuron |
| Peptide | Gene | Primary sites | Function |
|---|---|---|---|
| CRF | CRH | PVN, amygdala | Stress response |
| Urocortin 1 | UCN | Edinger-Westphal | Stress, appetite |
| Urocortin 2 | UCN2 | Brainstem | Stress, energy balance |
| Urocortin 3 | UCN3 | Perifornical area | Stress, metabolism |
The PVN is the primary source of CRF:
| Property | Details |
|---|---|
| Distribution | Cortex, amygdala, cerebellum, pituitary |
| Signaling | Gs-coupled, cAMP increase |
| Function | Anxiety, stress response |
| Antagonists | Pharmacological tools |
| Property | Details |
|---|---|
| Distribution | Hypothalamus, septum, brainstem |
| Signaling | Gs and Gi-coupled |
| Function | Stress coping, appetite |
| Ligands | Urocortins > CRF |
CRF neurons orchestrate the stress response:
CRF mediates:
CRF influences:
CRF dysregulation contributes to AD pathology:
PD involves CRF system alterations:
ALS shows CRF system changes:
HD involves CRF alterations:
CRF is central to stress-related disorders:
| Compound | Development status | Indication |
|---|---|---|
| Pexacerfont | Discontinued | Anxiety, depression |
| Verucerfont | Clinical trials | PTSD, anxiety |
| BMS-986020 | Preclinical | Stress disorders |
CSF CRF: Disease state marker
Imaging: CRHR1 PET ligands
Genetic markers: CRH polymorphisms
Paraventricular Hypothalamic Nucleus
Hypothalamic-Pituitary-Adrenal Axis
Amygdala Neurons
Locus Coeruleus Neurons
Stress Response in Neurodegeneration
The study of Crf Corticotropin Releasing Factor Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science. 1981. 1981. ↩︎
Sapolsky RM. The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuronal death. Biol Psychiatry. 2000. 2000. ↩︎
Jellinger KA. Neurobiology of anxiety and stress-related disorders. J Neural Transm Suppl. 2003. 2003. ↩︎
Zhao W, Beers DR, Appel SH. Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis. J Neuroimmune Pharmacol. 2013. 2013. ↩︎
Du X, Pang TY. Dysregulation of the hypothalamic-pituitary-adrenal axis in Huntington's disease. Neurobiol Dis. 2015. 2015. ↩︎